|
FBXW2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.56369999971507E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.838000E-02 |
| Normal-vs-Stage2 |
3.004900E-03 |
| Normal-vs-Stage3 |
2.69010036468842E-10 |
| Normal-vs-Stage4 |
2.08919992417123E-10 |
| Stage1-vs-Stage2 |
4.415700E-02 |
| Stage1-vs-Stage3 |
1.34530000028832E-07 |
| Stage1-vs-Stage4 |
7.19530000026225E-08 |
| Stage2-vs-Stage3 |
8.993900E-02 |
| Stage2-vs-Stage4 |
2.923900E-02 |
| Stage3-vs-Stage4 |
4.074800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.76029999979733E-07 |
| Normal-vs-AfricanAmerican |
1.490460E-02 |
| Normal-vs-Asian |
9.541200E-01 |
| Caucasian-vs-AfricanAmerican |
6.297600E-01 |
| Caucasian-vs-Asian |
1.724410E-01 |
| AfricanAmerican-vs-Asian |
2.992600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.3134999995238E-08 |
| Normal-vs-Female |
3.763400E-03 |
| Male-vs-Female |
1.525600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.296300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.375600E-03 |
| Normal-vs-Age(61-80Yrs) |
4.68990000168645E-08 |
| Normal-vs-Age(81-100Yrs) |
1.819180E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.338400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.391200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.222000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.507690E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.439600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.263400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.843700E-02 |
| Normal-vs-Grade 2 |
2.508300E-02 |
| Normal-vs-Grade 3 |
3.81989999631571E-08 |
| Normal-vs-Grade 4 |
7.17570447505977E-11 |
| Grade 1-vs-Grade 2 |
2.465800E-02 |
| Grade 1-vs-Grade 3 |
3.242900E-04 |
| Grade 1-vs-Grade 4 |
2.0120000000512E-06 |
| Grade 2-vs-Grade 3 |
2.424600E-04 |
| Grade 2-vs-Grade 4 |
9.44600000440943E-08 |
| Grade 3-vs-Grade 4 |
7.744000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.210400E-01 |
| Normal-vs-ccB subtype |
7.69030000014048E-07 |
| ccA subtype-vs-ccB subtype |
1.237770E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.50490000000647E-05 |
| Normal-vs-N1 |
1.618340E-02 |
| N0-vs-N1 |
2.456200E-01 |
|
|
